CHARITE UNIVERSITATSMEDIZIN

Cancer risk linked to p53 in ulcerative colitis: Study

A team of researchers led by Kimberly Hartl, a graduate student at the Berlin Institute for Medical Systems Biology of the Max Delbruck Center (MDC-BIMSB) and Charite - Universitatsmedizin, have shed new light on the role of the p53 tumor suppressor gene in the pathogenesis of ulcerative colitis (UC) - an inflammatory bowel disease that afflicts an estimated five million people worldwide and that is linked to an increased risk of colon cancer.